{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:04:24Z","timestamp":1771056264241,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Tribal Affairs, Govt. of India","award":["11019\/07\/2018-Sch"],"award-info":[{"award-number":["11019\/07\/2018-Sch"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/15\/2023-5901"],"award-info":[{"award-number":["EMDR\/SG\/15\/2023-5901"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11558-8","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:15:21Z","timestamp":1771053321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["STAT4 mediated modulation of T\u2013B cell interactions profiling: enhances antitumor immunity in non-small cell lung cancer (NSCLC)"],"prefix":"10.1007","volume":"53","author":[{"given":"Roshni","family":"Bibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koustav","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"issue":"7","key":"11558_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41571-025-01021-1","volume":"22","author":"Z Rahal","year":"2025","unstructured":"Rahal Z, El Darzi R, Moghaddam SJ, Cascone T, Kadara H (2025) Tumour and microenvironment crosstalk in NSCLC progression and response to therapy. Nat Rev Clin Oncol 22(7):463\u2013482. https:\/\/doi.org\/10.1038\/s41571-025-01021-1","journal-title":"Nat Rev Clin Oncol"},{"issue":"8036","key":"11558_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, Liu J, Chen S, Storrs E, Targino da Costa ALN, Houston A, Wendl MC, Jayasinghe RG, Iglesia MD, Ma C, Herndon JM, Southard-Smith AN, Liu X, Mudd J, Karpova A, Shinkle A, Goedegebuure SP, Abdelzaher ATMA, Bo P, Fulghum L, Ding L (2024) Tumour evolution and microenvironment interactions in 2D and 3D space. Nature 634(8036):1178\u20131186. https:\/\/doi.org\/10.1038\/s41586-024-08087-4","journal-title":"Nature"},{"key":"11558_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625814","volume":"16","author":"R Liu","year":"2025","unstructured":"Liu R, Shan W, Wang Z, Wang H, Li C, Yang L, Guo R (2025) Unveiling mitochondrial transfer in tumor immune evasion: mechanisms, challenges, and clinical implications. Front Immunol 16:1625814. https:\/\/doi.org\/10.3389\/fimmu.2025.1625814","journal-title":"Front Immunol"},{"issue":"1","key":"11558_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06167-1","volume":"23","author":"Q An","year":"2025","unstructured":"An Q, Duan L, Wang Y, Wang F, Liu X, Liu C, Hu Q (2025) Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment. J Transl Med 23(1):179. https:\/\/doi.org\/10.1186\/s12967-025-06167-1","journal-title":"J Transl Med"},{"issue":"4","key":"11558_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","volume":"21","author":"X Lei","year":"2024","unstructured":"Lei X, de Groot DC, Welters MJP, de Wit T, Schrama E, van Eenennaam H, Santegoets SJ, Oosenbrug T, van der Veen A, Vos JL, Zuur CL, de Miranda NFCC, Jacobs H, van der Burg SH, Borst J, Xiao Y (2024) CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cell Mol Immunol 21(4):374\u2013392. https:\/\/doi.org\/10.1038\/s41423-024-01133-1","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"11558_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56546-x","volume":"16","author":"L Desharnais","year":"2025","unstructured":"Desharnais L, Sorin M, Rezanejad M, Liu B, Karimi E, Atallah A, Swaby AM, Yu MW, Dor\u00e9 S, Hartner S, Fiset B, Wei Y, Kadang B, Rayes R, Joubert P, Camilleri-Bro\u00ebt S, Fiset PO, Quail DF, Spicer JD, Walsh LA (2025) Spatially mapping the tumour immune microenvironments of non-small cell lung cancer. Nat Commun 16(1):1345. https:\/\/doi.org\/10.1038\/s41467-025-56546-x","journal-title":"Nat Commun"},{"issue":"7948","key":"11558_CR7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin M, Rezanejad M, Karimi E, Fiset B, Desharnais L, Perus LJM, Milette S, Yu MW, Maritan SM, Dor\u00e9 S, Pichette \u00c9, Enlow W, Gagn\u00e9 A, Wei Y, Orain M, Manem VSK, Rayes R, Siegel PM, Camilleri-Bro\u00ebt S, Fiset PO, Walsh LA (2023) Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature 614(7948):548\u2013554. https:\/\/doi.org\/10.1038\/s41586-022-05672-3","journal-title":"Nature"},{"issue":"11","key":"11558_CR8","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41556-024-01508-6","volume":"26","author":"X Hao","year":"2024","unstructured":"Hao X, Shen Y, Liu J, Alexander A, Wu L, Xu Z, Yu L, Gao Y, Liu F, Chan HL, Li CH, Ding Y, Zhang W, Edwards DG, Chen N, Nasrazadani A, Ueno NT, Lim B, Zhang XH (2024) Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions. Nat Cell Biol 26(11):1971\u20131983. https:\/\/doi.org\/10.1038\/s41556-024-01508-6","journal-title":"Nat Cell Biol"},{"issue":"1","key":"11558_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70027","volume":"331","author":"RA Elsner","year":"2025","unstructured":"Elsner RA, Shlomchik MJ (2025) Coordinated regulation of Extrafollicular B cell responses by IL-12 and IFN\u03b3. Immunol Rev 331(1):e70027. https:\/\/doi.org\/10.1111\/imr.70027","journal-title":"Immunol Rev"},{"issue":"1","key":"11558_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57237-3","volume":"16","author":"JW Yoon","year":"2025","unstructured":"Yoon JW, Kim KM, Cho S, Cho MJ, Park S, Hwang D, Kim HR, Park SH, Cho JH, Jeong H, Choi JM (2025) Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease. Nat Commun 16(1):1962. https:\/\/doi.org\/10.1038\/s41467-025-57237-3","journal-title":"Nat Commun"},{"key":"11558_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669992","volume":"12","author":"E Renaude","year":"2021","unstructured":"Renaude E, Kroemer M, Borg C, Peixoto P, Hervouet E, Loyon R, Adot\u00e9vi O (2021) Epigenetic reprogramming of CD4+ helper T cells as a strategy to improve anticancer immunotherapy. Front Immunol 12:669992. https:\/\/doi.org\/10.3389\/fimmu.2021.669992","journal-title":"Front Immunol"},{"issue":"1","key":"11558_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10555-025-10253-7","volume":"44","author":"A Suraweera","year":"2025","unstructured":"Suraweera A, O\u2019Byrne KJ, Richard DJ (2025) Epigenetic drugs in cancer therapy. Cancer Metastasis Rev 44(1):37. https:\/\/doi.org\/10.1007\/s10555-025-10253-7","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"11558_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W, Sun Y, Peng A (2024) Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov 10(1):28. https:\/\/doi.org\/10.1038\/s41420-024-01803-z","journal-title":"Cell Death Discov"},{"issue":"8","key":"11558_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70322","volume":"6","author":"S Huang","year":"2025","unstructured":"Huang S, Li Z, Lin W, Xie R, Huang H (2025) RNA epigenetics in cancer: current knowledge and therapeutic implications. MedComm 6(8):e70322. https:\/\/doi.org\/10.1002\/mco2.70322","journal-title":"MedComm"},{"issue":"2","key":"11558_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ph18020207","volume":"18","author":"IS Alalhareth","year":"2025","unstructured":"Alalhareth IS, Alyami SM, Alshareef AH, Ajeibi AO, Al Munjem MF, Elfifi AA, Alsharif MM, Alzahrani SA, Alqaad MA, Bakir MB, Abdel-Wahab BA (2025) Cellular epigenetic targets and epidrugs in breast cancer therapy: mechanisms, challenges, and future perspectives. Pharmaceuticals (Basel, Switzerland) 18(2):207. https:\/\/doi.org\/10.3390\/ph18020207","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"11558_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","volume":"10","author":"J Song","year":"2025","unstructured":"Song J, Yang P, Chen C, Ding W, Tillement O, Bai H, Zhang S (2025) Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance. Signal Transduct Target Therapy 10(1):219. https:\/\/doi.org\/10.1038\/s41392-025-02266-z","journal-title":"Signal Transduct Target Therapy"},{"key":"11558_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000582","author":"R Bibi","year":"2025","unstructured":"Bibi R, George M, Sarkar K (2025) Epigenetic and epitranscriptomic modulation by STAT1: unraveling T helper cell differentiation in NSCLC. J Immunotherapy (Hagerstown Md : 1997). https:\/\/doi.org\/10.1097\/CJI.0000000000000582. https:\/\/doi.org\/10.1097\/CJI.0000000000000582 Advance online publication","journal-title":"J Immunotherapy (Hagerstown Md : 1997)"},{"key":"11558_CR18","doi-asserted-by":"publisher","first-page":"17639","DOI":"10.1038\/s41598-019-54065-6","volume":"9","author":"MM Silva","year":"2019","unstructured":"Silva MM, Rocha CRR, Kinker GS et al (2019) The balance between NRF2\/GSH antioxidant mediated pathway and DNA repair modulates cisplatin resistance in lung cancer cells. Sci Rep 9:17639. https:\/\/doi.org\/10.1038\/s41598-019-54065-6","journal-title":"Sci Rep"},{"issue":"2","key":"11558_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.15698\/mic2016.02.480","volume":"3","author":"S Khosla","year":"2016","unstructured":"Khosla S, Sharma G, Yaseen I (2016) Learning epigenetic regulation from mycobacteria. Microb Cell (Graz Austria) 3(2):92\u201394. https:\/\/doi.org\/10.15698\/mic2016.02.480","journal-title":"Microb Cell (Graz Austria)"},{"issue":"7","key":"11558_CR20","doi-asserted-by":"publisher","first-page":"104938","DOI":"10.1016\/j.jbc.2023.104938","volume":"299","author":"SA Haws","year":"2023","unstructured":"Haws SA, Miller LJ, Luz L, Kuznetsov DR, Trievel VI, Craciun RC, G., Denu JM (2023) Intrinsic catalytic properties of histone H3 lysine-9 methyltransferases preserve monomethylation levels under low S-adenosylmethionine. J Biol Chem 299(7):104938. https:\/\/doi.org\/10.1016\/j.jbc.2023.104938","journal-title":"J Biol Chem"},{"issue":"20","key":"11558_CR21","doi-asserted-by":"publisher","first-page":"33487","DOI":"10.18632\/oncotarget.16532","volume":"8","author":"N Tsuyama","year":"2017","unstructured":"Tsuyama N, Ennishi D, Yokoyama M, Baba S, Asaka R, Mishima Y, Terui Y, Hatake K, Takeuchi K (2017) Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de Novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas. Oncotarget 8(20):33487\u201333500. https:\/\/doi.org\/10.18632\/oncotarget.16532","journal-title":"Oncotarget"},{"issue":"1","key":"11558_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000536571","volume":"17","author":"J Fan","year":"2024","unstructured":"Fan J, Thanedar S, Ovechko V, Jana B (2024) Diffuse large B-Cell lymphoma with aberrant coexpression of CD5 and CD8 T-Cell markers. Case Rep Oncol 17(1):517\u2013523. https:\/\/doi.org\/10.1159\/000536571","journal-title":"Case Rep Oncol"},{"issue":"5","key":"11558_CR23","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.5114\/aoms.2018.77772","volume":"15","author":"MR Karim","year":"2019","unstructured":"Karim MR, Wang YF (2019) Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce Interleukin 10 and transforming growth factor \u03b21 in human peripheral blood. Archives Med Science: AMS 15(5):1176\u20131183. https:\/\/doi.org\/10.5114\/aoms.2018.77772","journal-title":"Archives Med Science: AMS"},{"issue":"10","key":"11558_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/biom10101429","volume":"10","author":"L Kennedy","year":"2020","unstructured":"Kennedy L, Sandhu JK, Harper ME, Cuperlovic-Culf M (2020) Role of glutathione in cancer: from mechanisms to therapies. Biomolecules 10(10):1429. https:\/\/doi.org\/10.3390\/biom10101429","journal-title":"Biomolecules"},{"issue":"2","key":"11558_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-03230-1","volume":"43","author":"R Bibi","year":"2025","unstructured":"Bibi R, George M, Sarkar K (2025) RNA-guided STAT3 modification fine tunes the epigenetic and epitranscriptomic regulation of CD4\u2009+\u2009T helper cell differentiation during non-small cell lung cancer (NSCLC). Med Oncol 43(2):102. https:\/\/doi.org\/10.1007\/s12032-025-03230-1","journal-title":"Med Oncol"},{"key":"11558_CR26","doi-asserted-by":"publisher","unstructured":"El Omari N, Bakrim S, Bakha M, Balahbib A, Bouyahya A, Ardianto C, Ming LC, Ser HL (2025) DNA methylation: its role and interaction with epigenetic modifications in cancer. Progress Microbes Mol Biology 8(1). https:\/\/doi.org\/10.36877\/pmmb.a0000458","DOI":"10.36877\/pmmb.a0000458"},{"key":"11558_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.972655","volume":"12","author":"FS Qiu","year":"2022","unstructured":"Qiu FS, He JQ, Zhong YS, Guo MY, Yu CH (2022) Implications of m6A methylation and microbiota interaction in non-small cell lung cancer: from basics to therapeutics. Front Cell Infect Microbiol 12:972655. https:\/\/doi.org\/10.3389\/fcimb.2022.972655","journal-title":"Front Cell Infect Microbiol"},{"key":"11558_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.67","volume":"8","author":"P Bhat","year":"2017","unstructured":"Bhat P, Leggatt G, Waterhouse N et al (2017) Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity. Cell Death Dis 8:e2836. https:\/\/doi.org\/10.1038\/cddis.2017.67","journal-title":"Cell Death Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11558-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:15:21Z","timestamp":1771053321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11558"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11558-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study involving human participants was reviewed and approved by the Ethics Committee of SRM Medical College Hospital and Research Centre, Kattankulathur, Tamil Nadu 603203, India. All human participants gave their written informed consent to participate in the study as per the Institutional Ethical Committee guidelines (Ethics Clearance Number: 2909\/IEC\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Signed informed consent was collected from all the patients and normal individuals who took part in the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"389"}}